Proceedings of the Korean Society of Plant Biotechnology Conference (한국식물생명공학회:학술대회논문집)
- 2002.04b
- /
- Pages.27-31
- /
- 2002
Mass Production of Paclitaxel by Plant Cell Culture
식물세포배양에 의한 항암제 Paclitaxel의 대량 생산
-
Choi, Hyung-Kyoon
(Samyang Genex Biotech Research Institute)
;
- Son, Joo-Sun (Samyang Genex Biotech Research Institute) ;
- Na, Gwang-Hee (Samyang Genex Biotech Research Institute) ;
- Hong, Seung-Suh (Samyang Genex Biotech Research Institute) ;
- Song, Jai-Young (Samyang Genex Biotech Research Institute)
-
최형균
(삼양제넥스 생명공학연구소)
;
- 손주선 (삼양제넥스 생명공학연구소) ;
- 나광휘 (삼양제넥스 생명공학연구소) ;
- 홍승서 (삼양제넥스 생명공학연구소) ;
- 송재영 (삼양제넥스 생명공학연구소)
- Published : 2002.04.26
Abstract
Samyang Genex succeeded in commercialization of anticancer agent-paclitaxel by plant cell culture technology. The core technology of Samyang Genex relating paclitaxel production includes cell line development, cell line preservation, cell culture, scale-up technology, and purification technology. On the basis of the research, Samyang Genex built the factory operated by CGMP (current good manufacturing practice). The
Keywords
- Cell culture;
- cell line development;
- commercialization;
- $Genexol^{TM}$;
- purification technology;
- scale-up technology